Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 11/2006

01.11.2006 | Clinical Investigation

Estimation of visual outcome without treatment in patients with subfoveal choroidal neovascularization in pathologic myopia

verfasst von: Ariko Kojima, Kyoko Ohno-Matsui, Satoshi Teramukai, Yoko Ishihara, Noriaki Shimada, Takeshi Yoshida, Yoshiharu Sugamoto, Takashi Tokoro, Manabu Mochizuki

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 11/2006

Einloggen, um Zugang zu erhalten

Abstract

Objective

To clarify prognostic factors of long-term visual outcome without treatment in patients with myopic choroidal neovascularization (CNV) and estimate a regression equation to predict visual acuity at 5 years after CNV onset.

Methods

Fifty-four eyes of 54 consecutive patients with high myopia and subfoveal CNV who did not receive treatment were identified using clinical records from 1988 to 2004. Photodynamic therapy not approved for myopic CNV in Japan during this period. The association of best-corrected visual acuity (BCVA) at 5 years after CNV onset with patient age, refractive error, axial length, initial BCVA, myopic retinopathy grade, duration of persistent hemorrhage, CNV size at onset, and size of hemorrhage around the CNV was analyzed using Spearman’s correlation and multiple linear regression analysis.

Results

BCVA at 5 years after onset was significantly associated with patient age, CNV size, and initial BCVA (P<0.05, Spearman’s correlation). The regression equation estimating BCVA at 5 years after CNV onset was based on age and initial BCVA (R 2=0.43). When subjects were divided into groups according to age (<40 and ≥40 years), CNV size, axial length and duration of persistent hemorrhage influenced BCVA at 5 years in patients under 40 years; while only initial BCVA was an influence in those at least 40 years old.

Conclusions

We developed a linear predictive model to estimate BCVA at 5 years after onset of myopic CNV without treatment based on the identified prognostic factors. This information might be important for managing patients with myopic CNV.
Literatur
1.
Zurück zum Zitat Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schpens CL (1984) Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91:1573–1581PubMed Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schpens CL (1984) Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91:1573–1581PubMed
2.
Zurück zum Zitat Axer-Siegel R, Ehrlich R, Weinberger D, Rosenblatt I, Shani L, Yassur Y, Priel E, Kramer M (2004) Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment. Am J Ophthalmol 138:602–607PubMedCrossRef Axer-Siegel R, Ehrlich R, Weinberger D, Rosenblatt I, Shani L, Yassur Y, Priel E, Kramer M (2004) Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment. Am J Ophthalmol 138:602–607PubMedCrossRef
3.
Zurück zum Zitat Curtin BJ, Karlin DB (1971) Axial length measurements and fundus changes of the myopic eye. Am J Ophthalmol 71:42–50 Curtin BJ, Karlin DB (1971) Axial length measurements and fundus changes of the myopic eye. Am J Ophthalmol 71:42–50
4.
Zurück zum Zitat Curtin BJ (1985) Basic science and clinical management. In: The myopias. Harper & Row, Philadelphia, pp 237–245 Curtin BJ (1985) Basic science and clinical management. In: The myopias. Harper & Row, Philadelphia, pp 237–245
5.
Zurück zum Zitat Ergun E, Heinzl H, Stur M (2004) Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. Am J Ophthalmol 138:434–438PubMedCrossRef Ergun E, Heinzl H, Stur M (2004) Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. Am J Ophthalmol 138:434–438PubMedCrossRef
6.
Zurück zum Zitat Hampton GR, Kohen D, Bird AC (1983) Visual prognosis of disciform degeneration in myopia. Ophthalmology 90:923–926PubMed Hampton GR, Kohen D, Bird AC (1983) Visual prognosis of disciform degeneration in myopia. Ophthalmology 90:923–926PubMed
7.
Zurück zum Zitat Hayashi K, Ohno-Matsui K, Yoshida T, Kobayashi K, Kojima A, Shimada N, Yasuzumi K, Futagami S, Tokoro T, Mochizuki M (2005) Characteristics of patients with a favorable natural course of myopic choroidal neovascularization. Graefe's Arch Clin Exp Ophthalmol 243:13–19CrossRef Hayashi K, Ohno-Matsui K, Yoshida T, Kobayashi K, Kojima A, Shimada N, Yasuzumi K, Futagami S, Tokoro T, Mochizuki M (2005) Characteristics of patients with a favorable natural course of myopic choroidal neovascularization. Graefe's Arch Clin Exp Ophthalmol 243:13–19CrossRef
8.
Zurück zum Zitat Hotchkiss ML, Fine SL (1981) Pathologic myopia and choroidal neovascularization. Am J Ophthalmol 91:177–183PubMed Hotchkiss ML, Fine SL (1981) Pathologic myopia and choroidal neovascularization. Am J Ophthalmol 91:177–183PubMed
9.
Zurück zum Zitat Kayazawa F, Tamura S, Tsuji T, Matsuda T, Kuwayama W, Machida T (1983) The influence of aging on vitreous fluorophotometry. J Jpn Ophthalmol Soc 87:380–383 Kayazawa F, Tamura S, Tsuji T, Matsuda T, Kuwayama W, Machida T (1983) The influence of aging on vitreous fluorophotometry. J Jpn Ophthalmol Soc 87:380–383
10.
Zurück zum Zitat Lam DS, Chan WM, Liu DT, Fan DS, Lai WW, Chong K (2004) Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up. Br J Ophthalmol 88:1315–1319PubMedCrossRef Lam DS, Chan WM, Liu DT, Fan DS, Lai WW, Chong K (2004) Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up. Br J Ophthalmol 88:1315–1319PubMedCrossRef
11.
Zurück zum Zitat Montero JA, Ruiz-Moreno JM (2005) Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularization. Br J Ophthalmol 87:173–176CrossRef Montero JA, Ruiz-Moreno JM (2005) Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularization. Br J Ophthalmol 87:173–176CrossRef
12.
Zurück zum Zitat Riise R (1988) Myopia as a cause of blindness. Acta Ophthalmol (Suppl) 185:109–110CrossRef Riise R (1988) Myopia as a cause of blindness. Acta Ophthalmol (Suppl) 185:109–110CrossRef
13.
Zurück zum Zitat Secreran M, Kuhn D, Soubrane G, Coscas G (1997) Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment. Eur J Ophthalmol 7:307–316 Secreran M, Kuhn D, Soubrane G, Coscas G (1997) Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment. Eur J Ophthalmol 7:307–316
14.
Zurück zum Zitat Sperduto RD, Seigel D, Roberts J, Rowland M (1983) Prevalence of myopia in the United States. Arch Ophthalmol 101:405–407PubMed Sperduto RD, Seigel D, Roberts J, Rowland M (1983) Prevalence of myopia in the United States. Arch Ophthalmol 101:405–407PubMed
15.
Zurück zum Zitat Steidl SM, Pruett RC (1997) Macular complications associated with posterior staphyloma. Am J Ophthalmol 123:181–187PubMed Steidl SM, Pruett RC (1997) Macular complications associated with posterior staphyloma. Am J Ophthalmol 123:181–187PubMed
16.
Zurück zum Zitat Tabandeh H, Flynn HW, Scott IU, Lewis ML, Rosenfeld PJ, Rodriguez F, Rodriguez A, Singerman LJ, Schiffman J (1999) Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization. Ophthalmology 106:2063–2067PubMedCrossRef Tabandeh H, Flynn HW, Scott IU, Lewis ML, Rosenfeld PJ, Rodriguez F, Rodriguez A, Singerman LJ, Schiffman J (1999) Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization. Ophthalmology 106:2063–2067PubMedCrossRef
18.
Zurück zum Zitat Terasaki H, Ishikawa K, Suzuki T, Nakamura M, Miyake K, Miyake Y (2003) Morphologic and angiographic assessment of the macula after macular translocation surgery with 360 degrees retinotomy. Ophthalmology 110:2403–2408PubMedCrossRef Terasaki H, Ishikawa K, Suzuki T, Nakamura M, Miyake K, Miyake Y (2003) Morphologic and angiographic assessment of the macula after macular translocation surgery with 360 degrees retinotomy. Ophthalmology 110:2403–2408PubMedCrossRef
19.
Zurück zum Zitat Tokoro T (1988) On the definition of pathologic myopia in group studies. Acta Ophthalmol 66:107–108 Tokoro T (1988) On the definition of pathologic myopia in group studies. Acta Ophthalmol 66:107–108
20.
Zurück zum Zitat Verteporfin in Photodynamic Therapy (VIP) Study Group (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia. 2-year results of a randomized clinical trial-VIP report no. 3. Ophthalmology 110:667–673CrossRef Verteporfin in Photodynamic Therapy (VIP) Study Group (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia. 2-year results of a randomized clinical trial-VIP report no. 3. Ophthalmology 110:667–673CrossRef
21.
Zurück zum Zitat Yoshida A, Murakami K, Kojima M (1986) Investigation of the vitreo-retino-ciliary barrier by vitreous fluorophotometry. Alteration of the inward permeability of the blood-retinal barrier and the diffusion coefficient of fluorescein in the vitreous with aging in normal subjects. J Jpn Ophthalmol Soc 90:589–594 Yoshida A, Murakami K, Kojima M (1986) Investigation of the vitreo-retino-ciliary barrier by vitreous fluorophotometry. Alteration of the inward permeability of the blood-retinal barrier and the diffusion coefficient of fluorescein in the vitreous with aging in normal subjects. J Jpn Ophthalmol Soc 90:589–594
22.
Zurück zum Zitat Yoshida T, Ohno-Matsui K, Ohtake Y, Takashima T, Futagami S, Baba T, Yasuzumi K, Tokoro T, Mochizuki M (2002) Long-term visual prognosis of choroidal neovascularization in high myopia. Ophthalmology 109:712–719PubMedCrossRef Yoshida T, Ohno-Matsui K, Ohtake Y, Takashima T, Futagami S, Baba T, Yasuzumi K, Tokoro T, Mochizuki M (2002) Long-term visual prognosis of choroidal neovascularization in high myopia. Ophthalmology 109:712–719PubMedCrossRef
23.
Zurück zum Zitat Yoshida T, Ohno-Matsui K, Yasuzumi K, Kojima A, Shimada N, Futagami S, Tokoro T, Mochizuki M (2003) Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 110:1297–1305PubMedCrossRef Yoshida T, Ohno-Matsui K, Yasuzumi K, Kojima A, Shimada N, Futagami S, Tokoro T, Mochizuki M (2003) Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 110:1297–1305PubMedCrossRef
Metadaten
Titel
Estimation of visual outcome without treatment in patients with subfoveal choroidal neovascularization in pathologic myopia
verfasst von
Ariko Kojima
Kyoko Ohno-Matsui
Satoshi Teramukai
Yoko Ishihara
Noriaki Shimada
Takeshi Yoshida
Yoshiharu Sugamoto
Takashi Tokoro
Manabu Mochizuki
Publikationsdatum
01.11.2006
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 11/2006
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-006-0324-4

Weitere Artikel der Ausgabe 11/2006

Graefe's Archive for Clinical and Experimental Ophthalmology 11/2006 Zur Ausgabe

Announcements

Announcements

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.